StockData
Establishment Labs Holdings Inc. logo

Establishment Labs Holdings Inc. (ESTA) stock

ESTANasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$70.80+1.29 (+1.86%)

Close on Nov 18, 2026Market cap $2.11BP/E –Yield –

Establishment Labs operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Establishment Labs's operating income for the twelve months ending Sep 30, 2026 was -$17.35M. For fiscal 2025 it was -$39.01M. The highest annual figure on record is -$19.98M in fiscal 2017.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$39.01M–
FY2024Dec 31, 2024-$49.99M–
FY2023Dec 31, 2023-$65.03M–
FY2022Dec 31, 2022-$39.66M–
FY2021Dec 31, 2021-$25.14M–
FY2020Dec 31, 2020-$27.92M–
FY2019Dec 31, 2019-$30.94M–
FY2018Dec 31, 2018-$23.86M–
FY2017Dec 31, 2017-$19.98M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$2.62M–
Q2 FY2026Jun 30, 2026-$4.29M–
Q1 FY2026Mar 31, 2026-$6.51M–
Q4 FY2025Dec 31, 2025-$3.93M–
Q3 FY2025Sep 30, 2025-$4.03M–
Q2 FY2025Jun 30, 2025-$14.11M–
Q1 FY2025Mar 31, 2025-$16.95M–
Q4 FY2024Dec 31, 2024-$18.67M–
Q3 FY2024Sep 30, 2024-$13.14M–
Q2 FY2024Jun 30, 2024-$9.34M–
Q1 FY2024Mar 31, 2024-$8.83M–
Q4 FY2023Dec 31, 2023-$22.12M–
Q3 FY2023Sep 30, 2023-$21.04M–
Q2 FY2023Jun 30, 2023-$13.71M–
Q1 FY2023Mar 31, 2023-$8.16M–
Q4 FY2022Dec 31, 2022-$13.16M–
Q3 FY2022Sep 30, 2022-$10.52M–
Q2 FY2022Jun 30, 2022-$10.41M–
Q1 FY2022Mar 31, 2022-$5.58M–
Q4 FY2021Dec 31, 2021-$9.37M–
Q3 FY2021Sep 30, 2021-$9.04M–
Q2 FY2021Jun 30, 2021-$4.63M–
Q1 FY2021Mar 31, 2021-$2.10M–
Q4 FY2020Dec 31, 2020-$8.02M–
Q3 FY2020Sep 30, 2020-$2.59M–
Q2 FY2020Jun 30, 2020-$9.60M–
Q1 FY2020Mar 31, 2020-$7.71M–
Q4 FY2019Dec 31, 2019-$4.41M–
Q3 FY2019Sep 30, 2019-$8.77M–
Q2 FY2019Jun 30, 2019-$9.38M–
Q1 FY2019Mar 31, 2019-$8.39M–
Q4 FY2018Dec 31, 2018-$8.62M–
Q3 FY2018Sep 30, 2018-$6.05M–
Q2 FY2018Jun 30, 2018-$6.32M–
Q1 FY2018Mar 31, 2018-$2.88M–
Q4 FY2017Dec 31, 2017-$4.59M–
Q3 FY2017Sep 30, 2017-$5.97M–
Q2 FY2017Jun 30, 2017-$5.48M–

More Establishment Labs figures

See a number that looks wrong?